SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
老迟到的可兰
Lv2
102 积分
2023-07-26 加入
最近求助
最近应助
互助留言
Mechanisms of immune activation and regulation: lessons from melanoma
7天前
已完结
In situ engineering of mRNA-CAR T cells using spleen-targeted ionizable lipid nanoparticles to eliminate cancer cells
8天前
已完结
Construction and characterization of human CD7-specific single-chain Fv immunotoxins
13天前
已完结
Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7
13天前
已关闭
Construction and characterization of human CD7-specific single-chain Fv immunotoxins
13天前
已完结
Inserting EF1α-driven CD7-specific CAR at CD7 locus reduces fratricide and enhances tumor rejection
14天前
已完结
Monoclonal antibodies developed for diagnosis of t cell and very immature leukemias
14天前
已关闭
Therapy with CD7 monoclonal antibody TH‐69 is highly effective for xenografted human T‐cell ALL
15天前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
15天前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
15天前
已完结
没有进行任何应助
感谢,点赞
7天前
感谢,点赞
8天前
不需要了【积分已退回】
13天前
感谢,点赞
13天前
不需要了【积分已退回】
14天前
感谢,点赞
15天前
感谢,点赞
15天前
感谢,点赞
15天前
感谢,点赞
15天前
感谢,点赞
15天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论